TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 44 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $392,752 | +13.2% | 22,102 | +15.1% | 0.00% | – |
| Q2 2023 | $346,926 | +84.5% | 19,199 | +28.3% | 0.00% | – |
| Q1 2023 | $188,000 | +112474.9% | 14,969 | +31.9% | 0.00% | – |
| Q4 2022 | $167 | -99.9% | 11,351 | +13.0% | 0.00% | – |
| Q3 2022 | $172,000 | +21.1% | 10,042 | +3.6% | 0.00% | – |
| Q2 2022 | $142,000 | +111.9% | 9,693 | +145.1% | 0.00% | – |
| Q1 2022 | $67,000 | -98.3% | 3,954 | -97.7% | 0.00% | – |
| Q4 2021 | $3,932,000 | +5517.1% | 174,736 | +5298.1% | 0.00% | – |
| Q3 2021 | $70,000 | -53.3% | 3,237 | -37.3% | 0.00% | – |
| Q2 2021 | $150,000 | -57.4% | 5,162 | -52.7% | 0.00% | – |
| Q1 2021 | $352,000 | -49.3% | 10,912 | -35.0% | 0.00% | – |
| Q4 2020 | $694,000 | – | 16,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |